Old Web
English
Sign In
Acemap
>
authorDetail
>
AL Petzer
AL Petzer
Medicine
Oncology
Internal medicine
Ixazomib
Progression-free survival
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Relapse protection following early CMV reactivation after HSCT is limited to HLA-C KIR ligand homozygous recipients.
2021
Alexander Nikoloudis
Helga Wagner
Sigrid Machherndl-Spandl
Veronika Buxhofer-Ausch
Irene Strassl
Olga Stiefel
Dagmar Wipplinger
Robert Milanov
Emine Kaynak
Petra Hasengruber
Michaela Binder
Ansgar Weltermann
AL Petzer
Dominik Wolf
David Nachbaur
Johannes Clausen
Show All
Source
Cite
Save
Citations (0)
Improvement In Colorectal Cancer Outcomes Over Time is Limited To Patients With Left-Sided Disease
2021
Holger Rumpold
Monika Hackl
AL Petzer
Dominik Wolf
Show All
Source
Cite
Save
Citations (0)
Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial)
2020
Heinz Ludwig
Bela Hausmann
Martin Schreder
Wolfram Pönisch
Niklas Zojer
Stefan Knop
Eberhard Gunsilius
Alexander Egle
AL Petzer
Hermann Einsele
Roman Hájek
Katja Weisel
Karl Jochen Krenosz
Alois B. Lang
Daniel Lechner
Richard Greil
David Berry
Show All
Source
Cite
Save
Citations (0)
1